Items where Author is "Nahand, J. S."

Article

(2024) Analyzing the expression pattern of the noncoding RNAs (HOTAIR, PVT-1, XIST, H19, and miRNA-34a) in PBMC samples of patients with COVID-19, according to the disease severity in Iran during 2022-2023: A cross-sectional study. Health Science Reports. p. 13.

(2023) Evaluation of MicroRNAs expression pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU, and Diabetic COVID-19 patients. Intervirology. pp. 63-76. ISSN 0300-5526

(2023) Viral Nanoparticles-Mediated Delivery of Therapeutic Cargo. Advanced Therapeutics. p. 19.

(2022) Evaluation of Cellular miR-122 Expression in Association with the Presence of Varicella-Zoster Virus among Central Nervous System Tumors. International Journal of Cancer Management. p. 8. ISSN 2538-4422

(2019) microRNAs: Key players in virus-associated hepatocellular carcinoma. Journal of Cellular Physiology. pp. 12188-12225. ISSN 0021-9541

(2018) Breast cancer diagnosis: Imaging techniques and biochemical markers. Journal of Cellular Physiology. pp. 5200-5213. ISSN 0021-9541

(2018) Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy. Cancer Letters. pp. 95-104. ISSN 0304-3835

(2018) MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers. Journal of Cellular Physiology. pp. 3016-3023. ISSN 1097-4652 (Electronic) 0021-9541 (Linking)

(2018) miRNA-based strategy for modulation of influenza A virus infection. Epigenomics. pp. 829-844. ISSN 1750-1911

(2016) Boron neutron capture therapy: Moving toward targeted cancer therapy. Journal of Cancer Research and Therapeutics. pp. 520-525. ISSN 0973-1482

(2016) Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies. Current Cancer Drug Targets. pp. 773-788. ISSN 1568-0096